Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 112, 2016, Issue in Progress
Previous Article Next Article

Protective effects of formononetin against rhabdomyolysis-induced acute kidney injury by upregulating Nrf2 in vivo and in vitro

Author affiliations

Abstract

Acute kidney injury (AKI) is a well-known organ injury frequently observed after rhabdomyolysis (RM). The purposes of this study are to investigate the protective effects of formononetin on RM-mediated AKI and to elucidate the involvement of nuclear factor erythroid 2-related factor 2 (Nrf2) in preventing apoptosis in vivo and in vitro. A rat model of RM was induced by an injection of glycerol. The renal histopathological changes, apoptosis of renal tubular cells and ultrastructural conditions showed significant amelioration after treatment with formononetin in rats. A formononetin dose-dependent study caused the upregulation of multidrug resistance associated proteins (MRPs) that resulted in reduced indoxyl sulfate (IS) concentrations in plasma and promoted its urinary excretion after renal injury. Formononetin increased the expression of Nrf2-mediated proteins such as BCL-XL, BCL-2 and decreased BAX, cytochrome c, caspase-9 and caspase-3 in RM-mediated AKI rats. Moreover, the changes of Nrf2 and BCL-2 family members were abrogated by Nrf2 antagonist retinoic acid (RA) formononetin-treated rats. In vitro evidence also directly demonstrated the effect of formononetin on Nrf2 and its related proteins could be reversed by brusatol (Nrf2 antagonist). In conclusion, formononetin provided renal protection due to the promotion of anti-apoptosis by Nrf2-mediated regulation of proteins.

Graphical abstract: Protective effects of formononetin against rhabdomyolysis-induced acute kidney injury by upregulating Nrf2 in vivo and in vitro

Back to tab navigation

Supplementary files

Article information


Submitted
12 Aug 2016
Accepted
04 Nov 2016
First published
08 Nov 2016

RSC Adv., 2016,6, 110874-110883
Article type
Paper

Protective effects of formononetin against rhabdomyolysis-induced acute kidney injury by upregulating Nrf2 in vivo and in vitro

D. Huang, C. Wang, Q. Meng, Z. Liu, X. Huo, H. Sun, S. Yang, X. Ma, J. Peng and K. Liu, RSC Adv., 2016, 6, 110874
DOI: 10.1039/C6RA20339F

Social activity

Search articles by author

Spotlight

Advertisements